Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis
- 27 July 2006
- journal article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 13 (23), 1645-1656
- https://doi.org/10.1038/sj.gt.3302821
Abstract
Human immunodeficiency virus-1 (HIV-1) infection in the central nervous system (CNS) may lead to neuronal loss and progressively deteriorating CNS function: HIV-1 gene products, especially gp120, induce free radical-mediated apoptosis. Reactive oxygen species (ROS), are among the potential mediators of these effects. Neurons readily form ROS after gp120 exposure, and so might be protected from ROS-mediated injury by antioxidant enzymes such as Cu/Zn-superoxide dismutase (SOD1) and/or glutathione peroxidase (GPx1). Both enzymes detoxify oxygen free radicals. As they are highly efficient gene delivery vehicles for neurons, recombinant SV40-derived vectors were used for these studies. Cultured mature neurons derived from NT2 cells and primary fetal neurons were transduced with rSV40 vectors carrying human SOD1 and/or GPx1 cDNAs, then exposed to gp120. Apoptosis was measured by terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) assay. Transduction efficiency of both neuron populations was >95%, as assayed by immunostaining. Transgene expression was also ascertained by Western blotting and direct assays of enzyme activity. Gp120 induced apoptosis in a high percentage of unprotected NT2-N. Transduction with SV(SOD1) and SV(GPx1) before gp120 challenge reduced neuronal apoptosis by >90%. Even greater protection was seen in cells treated with both vectors in sequence. Given singly or in combination, they protect neuronal cells from HIV-1-gp120 induced apoptosis. We tested whether rSV40 s can deliver antioxidant enzymes to the CNS in vivo: intracerebral injection of SV(SOD1) or SV(GPx1) into the caudate putamen of rat brain yielded excellent transgene expression in neurons. In vivo transduction using SV(SOD1) also protected neurons from subsequent gp120-induced apoptosis after injection of both into the caudate putamen of rat brain. Thus, SOD1 and GPx1 can be delivered by SV40 vectors in vitro or in vivo. This approach may merit consideration for therapies in HIV-1-induced encephalopathy.Keywords
This publication has 59 references indexed in Scilit:
- Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson's diseaseNeurobiology of Disease, 2006
- Gene therapy for neurodegenerative and ocular diseases using lentiviral vectorsClinical Science, 2005
- Current status of gene therapy strategies to treat HIV/AIDSMolecular Therapy, 2005
- Human Immunodeficiency Virus Type 1 gp120 Induces Apoptosis in Human Primary Neurons through Redox-Regulated Activation of Neutral SphingomyelinaseJournal of Neuroscience, 2004
- HIV associated neurodegeneration requires p53 in neurons and microgliaThe FASEB Journal, 2004
- Glutathione Peroxidase Overexpression Inhibits CytochromecRelease and Proapoptotic Mediators to Protect Neurons From Experimental StrokeStroke, 2003
- Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selectionGene Therapy, 1999
- In VivoTrapping of Nitric Oxide in the Brain of Neonatal Rats Treated with the HIV-1 Envelope Protein gp 120: Protective Effects of α-Phenyl-tert-butylnitroneBiochemical and Biophysical Research Communications, 1996
- Amplification of superoxide anion generation in phagocytic cells by HIV-1 infectionFEBS Letters, 1993
- Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicityNeuron, 1991